drugset / Trial / NCT00797108
A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test if intravenous sulopenem and an oral drug, PF-03709270 are safe and effective in patients that are hospitalized with community acquired pneumonia.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ceftriaxone | Other / unclassified | 2 g | Intravenous |
| Subject | Sulopenem | Small molecule | 600 mg | Intravenous |
| Comparator | amoxicillin/clavulanate | Unknown | 400 mg | Oral |
| Subject | sulopenem etzadroxil | Small molecule | 1000 mg | Oral |